Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
It is possible that the anti-inflammatory CRP reductions observed in the STEP and SELECT trials require the full doses used in those studies
Human Data: Only one registered clinical trial (Phase I) exists, with unknown status since 2016
T-ALL PDXs were treated with vehicle, ATO (2.5 mg/kg), MTX (5 mg/kg for BCP-ALL
Why Laboratories Source Glow | GHK-CU, TB-500, BPC-157 Blend Procurement and research teams often select this catalog item because it supports: Clear research-use labeling for compliance-aligned purchasing Consistent product identification across multi-lot studies Fit for reference, screening, and mechanistic laboratory models Straightforward catalog support for planning and documentation Study Planning and Quality Documentation Before starting experimental work with Glow | GHK-CU, TB-500, BPC-157 Blend , review any COA or quality files provided with the shipment
Sterility verification and endotoxin-free certification are required for reliable laboratory work
